Summary
- Current Price
- As of today, MESO price is $15.68, up +7.54% on
- Current Price All-Time High
- MESO price is currently -85.25% below its historical high of $106.34 set on
- Market Cap
- MESO current market cap is $2B, up +19.75% over the past 365 days
- PE Ratio
- MESO PE ratio is unknown
- Revenue
- MESO current annual revenue is $17.17M, up +190.90% year-over-year
- Next Earnings
- The next earnings release for MESO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Mesoblast Limited |
| Ticker | NASDAQ: MESO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | mesoblast.com |
| Employees | 73 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $15.68 | |
| Price, 1D Change | +7.54% | |
| $2B | ||
| - | ||
| - | ||
| 1.44 | ||
| $17M | ||
| Revenue, 1Y Change | +190.90% | |
| -$0.84 | ||
| EPS, 1Y Change | +5.28% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MBLTY | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.84 | ||
| EPS Estimate | -$0.10 | |
| EPS Est. Change | +88.16% | |
| $17.17M | ||
| Revenue Estimate | $175.49M | |
| Revenue Est. Change | +922.17% | |
| Current Price | $15.68 | |
| Price Target | - | $35.00 |
| Price Tgt. Change | - | +123.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.89 | - | |
| -$0.73 | -$0.84 | -15.66% | |
| -$0.10 | N/A | +88.16% | |
| $0.17 | N/A | +120.14% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.29M | $5.90M | -19.04% | |
| $27.57M | $17.17M | -37.72% | |
| $175.49M | N/A | +922.17% | |
| $327.38M | N/A | +1,806.83% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $15.68 | |
| $15.55 | ||
| SMA 200 vs Price | -0.82% | |
| $17.61 | ||
| SMA 50 vs Price | +12.32% | |
| 1.44 | ||
| $0.81 | ||
| 43.00 | ||
| 69.36% | ||
| 67.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $17.17M | ||
| -$0.84 | ||
| $5.66M | ||
| 32.96% | ||
| -$62.42M | ||
| -363.58% | ||
| -$101.97M | ||
| -593.92% | ||
| -$56.03M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.21 | ||
| 1.99 | ||
| 1.77 | ||
| - | ||
| - | ||
| 4.78 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 353.59 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $597.44M | ||
| $161.55M | ||
| $784.68M | ||
| $204.35M | ||
| $187.24M | ||
| $102.63M | ||
| $128.16M | ||
| $56.84M | ||
| $19.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $119.14M | ||
| $68.08M | ||
| $11.51M | ||
| $0.00 | ||
| $6.39M | ||
| $0.00 | ||
| $247.60K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$56.47M | ||
| $119.80K | ||
| $153.69M | ||
| $728.80K | ||
| -$57.20M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jefferies | → | |
| Jefferies | → | |
| Piper Sandler | → | |
| Jefferies | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | → | |
| Jefferies | → |
Analyst sentiment
Institutional ownership
Screeners with MESO
FAQ
What is the ticker symbol for Mesoblast Limited?
The ticker symbol for Mesoblast Limited is NASDAQ:MESO
Does Mesoblast Limited pay dividends?
No, Mesoblast Limited does not pay dividends
What sector is Mesoblast Limited in?
Mesoblast Limited is in the Healthcare sector
What industry is Mesoblast Limited in?
Mesoblast Limited is in the Biotechnology industry
What country is Mesoblast Limited based in?
Mesoblast Limited is headquartered in Australia
When did Mesoblast Limited go public?
Mesoblast Limited initial public offering (IPO) was on January 20, 2010
Is Mesoblast Limited in the S&P 500?
No, Mesoblast Limited is not included in the S&P 500 index
Is Mesoblast Limited in the NASDAQ 100?
No, Mesoblast Limited is not included in the NASDAQ 100 index
Is Mesoblast Limited in the Dow Jones?
No, Mesoblast Limited is not included in the Dow Jones index
When was Mesoblast Limited last earnings report?
Mesoblast Limited's most recent earnings report was on February 26, 2026
When does Mesoblast Limited report earnings?
The next expected earnings date for Mesoblast Limited is August 27, 2026
Data Sources & References
- MESO Official Website www.mesoblast.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1345099/000134509926000020/0001345099-26-000020-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1345099/000134509925000067/0001345099-25-000067-index.htm
- MESO Profile on Yahoo Finance finance.yahoo.com/quote/MESO
- MESO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/meso